Our panelists will discuss diabetes management strategies to help you enhance your ability to prescribe optimal treatment therapies and medical interventions for individuals living with type 2 diabetes. Following the presentation, speakers will be available for a Q&A session and will showcase four case studies to explore treatment decision making related to real-world clinical cases.
1. Review the use of glucose-lowering medication for microvascular and macrovascular risk reduction.
2. Insights into agent-specific considerations as they relate to diabetes’ clinical course among currently available SGLT-2 inhibitors, GLP-1 receptor agonists, dual GIP-GLP-1 receptor agonists, and other medications.
3. Identification of strategies to remove barriers to guideline-directed therapy.
Director, USC Westside Center for Diabetes
Profession, Keck School of Medicine of USC
Director, USC Clinical Diabetes Programs
Associate Professor/Clinical
Department of Medicine
Division of Diabetes
UT Health
Nurse Practitioner
Division of Endocrinology
Henry Ford Health System
Medical Director at the AdventHealth Diabetes Institute, Senior Investigator, Diabetes Program Lead at the Translational Research Institue
Translational Research, Infectious Disease